Technology
New evidence shows tirzepatide and semaglutide strongly protect the heart
2025-11-21 23:10
440 views
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabe...
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabetes. While companies have claimed large differences favoring their own medications, researchers found only modest distinctions between the two blockbuster GLP-1 drugs.
Related Articles
Trump’s Gaza ‘mandate’ and the mirage of global legitimacy
476 views
The Shark PowerPro is the best-value vacuum cleaner I've tested – and it's ideal for most households
436 views
Truth on Myanmar finally prevails in US Congress
349 views
‘Glorious’ streaming service offers British thrillers for half Netflix’s price
433 views